Assessment of real-life patient handling experience of AVT02 administered subcutaneously via autoinjector in patients with moderate to severe active rheumatoid arthritis: an open-label, single-arm clinical trial, then an extension phase of AVT02 administered with a prefilled syringe

Nemanja Damjanova School of Medicine, University of Belgrade, Belgrade, SerbiaView further author information

Nana Kirvalidzeb Department of Traumatology and Orthopedics, Georgian Dutch Hospital LLC, Tbilisi, GeorgiaView further author information

Nana Kurashvilic Traumatology, Aleksandre Aladashvili Clinic LLC, Tbilisi, GeorgiaView further author information

Fausto Bertid Clinical and Medical Affairs, Alvotech Swiss, Zürich, SwitzerlandView further author information

Matjaz Steigerd Clinical and Medical Affairs, Alvotech Swiss, Zürich, SwitzerlandView further author information

Joanna Sobierskad Clinical and Medical Affairs, Alvotech Swiss, Zürich, SwitzerlandView further author information

Eric Guenzie Development and Project Management, UGA Biopharma GmbH, Hennigsdorf, GermanyView further author information

Hendrik Ottof Clinical and Medical Affairs, Alvotech Germany GmbH, Jülich, GermanyView further author information

Abid Sattarg Clinical and Medical Affairs, Alvotech UK Ltd, London, UKView further author information

Halimu N. Haliduolaf Clinical and Medical Affairs, Alvotech Germany GmbH, Jülich, GermanyView further author information

Elin Edwaldh Combination Products & Devices, Alvotech Iceland, Reykjavik, IcelandView further author information

Heimo Stroissnigf Clinical and Medical Affairs, Alvotech Germany GmbH, Jülich, GermanyCorrespondence[email protected]
View further author information

Citations (1)

Keep up to date with the latest research on this topic with citation updates for this article.